Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1983-06-30
1985-03-19
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
424 19, 424 35, A61K 924, A61K 922, A61K 962
Patent
active
045058903
ABSTRACT:
A controlled release pharmaceutical formulation which undergoes substantially zero order release of active drug is provided, preferably in the form of a coated tablet, containing a core portion from which the angiotensin converting enzyme inhibitor (S)-1-[3-(benzoylthio)-2-methyl-1-oxopropyl]-L-proline is slowly released over a controlled length of time. The core also includes one or more hydrocolloid gelling agents having a viscosity of within the range of from about 8000 to about 100,00 centipoises in 2% solution at 20.degree. C., such as hydroxypropylmethyl cellulose and/or methyl cellulose, one or more inert fillers or excipients, one or more lubricants, and optionally one or more anti-adherents such as silicon dioxide and water. The above-described core is coated with a conventional pharmaceutical coating composition. A method of using such controlled release formulations in treating hypertension is also provided.
REFERENCES:
patent: 3065143 (1960-04-01), Christenson et al.
patent: 3427378 (1969-02-01), Henderson et al.
patent: 3444290 (1969-05-01), Wal et al.
patent: 3458622 (1969-03-01), Hill
patent: 3555151 (1971-01-01), Kaplan et al.
patent: 3574820 (1971-04-01), Johnson et al.
patent: 3976764 (1976-08-01), Watanabe et al.
patent: 4140755 (1979-02-01), Sheth
patent: 4173626 (1979-11-01), Dempski et al.
patent: 4248857 (1981-02-01), DeNeale et al.
patent: 4252786 (1981-02-01), Weiss et al.
patent: 4259314 (1981-03-01), Lowey
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309405 (1982-01-01), Guley et al.
Jain Nemichand B.
Patel Mahendra R.
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Rodney Burton
Rose Shep K.
LandOfFree
Controlled release formulation and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release formulation and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-752505